Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
letter
. 2011 May;49(5):2080–2081. doi: 10.1128/JCM.00153-11

First Report of Streptococcus pneumoniae Serotype 6D in South America

Erik Mercado 1, Velusamy Srinivasan 2, Paulina Hawkins, Sopio Chochua 3, Theresa Ochoa 4, Bernard Beall, Lesley McGee 5,*
PMCID: PMC3122696  PMID: 21430101

Streptococcus pneumoniae includes the two serotypes 6A and 6B as well as two recently discovered serotypes, 6C and 6D, in which the wciNα gene is replaced by wciNβ within the cps locus. Serotype 6D occurrence in Asia (2, 4), the Fiji islands (5) and Europe (7, 9) has recently been reported. To our knowledge, we describe here the first description of serotype 6D isolates identified within the Americas.

Using the CDC serogroup 6 serotyping scheme (8), we identified 155 serogroup 6 isolates within a larger collection (n = 693) taken from nasopharyngeal carriage in children <2 years old in Peru (2007 to 2009; 541 strains) (unpublished data) and invasive pneumococcal disease (IPD) surveillance in children in Lima hospitals (2006 to 2009; 152 strains) (reference 10 and unpublished data). Among the 155 serogroup 6 isolates, 26, 105, and 22 isolates were identified as serotypes, 6A, 6B, and 6C, respectively (Table 1). We tentatively identified two 6D isolates on the basis of positive reactions with factor sera for serotype 6B (factor 6c) and serotype 6C (factor 6d) and a negative reaction with factor serum for serotype 6A (factor 6b). We verified the serologic results for all 155 serogroup 6 isolates using a recently developed PCR scheme that efficiently resolves all four serogroup 6 serotypes (6). This scheme discriminates between serotypes 6A/6C and 6B/6D using wciP allele-specific reactions. The presence or absence of wciNβ determined by a second reaction subsequently allowed resolution into all four serotypes (Table 1).

Table 1.

Quellung and PCR results for 155 serogroup 6 isolates

Serotype No. of isolates Reaction with factor seruma
Reaction with serotype-specific PCRb
6b 6c 6d wciP584g (6A/6C) wciP584S (6B/6D) wciNβ (6C/6D)
6A 26 + +
6B 105 + +
6C 22 + + +
6D 2 + + + +
a

Factor sera described by Melnick et al. (8).

b

Method of Jin et al. (6).

The two 6D isolates, both from carriage, shared the new multilocus sequence typing (MLST) profile ST6148 (ST6148, 8-8-263-12-6-104-14) and were both fully susceptible to a variety of antimicrobial agents by broth microdilution. ST6148 is unrelated to previously described 6D genotypes on the MLST website (http://spneumoniae.mlst.net/, last accessed on 5 January 2011). It is, however, highly related to serotype 6A and 6B isolates both from carriage and invasive disease that were characterized from this same study, differing only at the recP allele. These data, together with data published elsewhere, show identical or related multilocus sequence types shared between serotype 6C or 6D strains containing wciNβ and 6A or 6B strains that contain wciNα (3, 4, 7). This suggests that the two different wciN genes are frequently horizontally transferred between different serogroup 6 strains in nature to effect intraserogroup 6 capsular switch events. On the basis of these genotype observations it also circumstantially appears likely that in some cases wciP is cotransferred with wciN, which could effect, for example, a serotype 6A to serotype 6D capsular switch.

In summary, we believe that this is the first reported detection of serotype 6D among pneumococcal isolates recovered in South America or elsewhere in the western hemisphere, despite the fact that our U.S.-based surveillance has been vigilant for its appearance using serologic and PCR-based approaches for 6D detection (3, 8). The work presented here validates serotype 6D as the 92nd serotype identifiable by using CDC pneumococcal typing sera (Table 1). Serotype 6C was not effectively targeted by the pneumococcal 7-valent conjugate vaccine according to recent IPD surveillance data (3); however, there are no existing comparable data for serotype 6D. It is hoped that the recently implemented 13-valent conjugate vaccine (1) will effectively target all serogroup 6 pneumococcal diseases.

Acknowledgments

This work was supported in part by PATH. Erik Mercado attended a 3-month training through the Global Strain Bank project, a project funded by PATH.

We acknowledge the use of the pneumococcal MLST database, which is located at the Imperial College, London, and is funded by the Wellcome Trust.

Footnotes

Published ahead of print on 23 March 2011.

Contributor Information

Erik Mercado, Insituto de Medicina Tropical, Universidad Peruana Cayetano Heredia, Lima, Peru.

Velusamy Srinivasan, Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.

Sopio Chochua, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Theresa Ochoa, Instituto de Medicina Tropical, Universidad Peruana Cayetano Heredia, Lima, Peru.

Lesley McGee, Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.

REFERENCES

  • 1. Bocchini J. A., et al. 2010. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics 126:186–190 [DOI] [PubMed] [Google Scholar]
  • 2. Bratcher P. E., Park I. H., Hollingshead S. K., Nahm M. H. 2009. Production of a unique pneumococcal capsule serotype belonging to serotype 6. Microbiology 155:576–583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Carvalho M. D. G., et al. 2009. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J. Clin. Microbiol. 47:554–559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Choi E. H., et al. 2010. Prevalence and genetic structure of Streptococcus pneumoniae serotype 6D, South Korea. Emerg. Infect. Dis. 16:1751–17653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Jin P., et al. 2009. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J. Infect. Dis. 200:1375–1380 [DOI] [PubMed] [Google Scholar]
  • 6. Jin P., et al. 2009. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J. Clin. Microbiol. 47:2470–2474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Kuch A., Sadowy E., Skoczynska A., Hryneiwciz W. 2010. First report of Streptococcus pneumoniae serotype 6D isolates from invasive infections. Vaccine 28:64606–66407 [DOI] [PubMed] [Google Scholar]
  • 8. Melnick N., Thompson T. A., Beall B. 2010. Serotype-specific typing antisera for pneumococcal serogroup 6 serotypes 6A, 6B, and 6C. J. Clin. Microbiol. 48:2311–2312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Nahm M. H., et al. 2011. A report of Streptococcus pneumoniae serotype 6D in Europe. J. Med. Microbiol. 60:46–48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Ochoa T. J., et al. 2010. Invasive pneumococcal diseases among hospitalized children in Lima, Peru. Rev. Panam. Salud Publica 28:121–127 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES